Joo-youn S. Cho
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 185 publications
Bioequivalence of two rabeprazole formulations and pharmacokinetic variability by CYP2C19 genotype and sex in healthy Korean participants: A four-period replicated crossover study.
Journal: Clinical pharmacology in drug development
Published: March 15, 2026
Plasma Metabolomes Identify Distinct Asthma Metabotypes: Findings From the COREA Cohort.
Journal: Allergy
Published: March 03, 2026
Urinary metabolomics identifies isoleucine as a prognostic biomarker for progression of diabetic kidney disease.
Journal: Frontiers in endocrinology
Published: January 14, 2026
Clinical CYP2D6-Mediated Pharmacokinetic Drug-Drug Interactions of DA-8010 with Paroxetine or Mirabegron in Healthy Korean Participants.
Journal: Drug design, development and therapy
Published: January 08, 2026
Exploratory comparative pharmacokinetic study of a fixed-dose combination of telmisartan/amlodipine/chlorthalidone: half-dose (20/2.5/6.25 mg) versus conventional dose (40/5/12.5 mg).
Journal: Translational and clinical pharmacology
Published: December 05, 2025
Circulating 1-Methylnicotinamide Predicts Dupilumab Response in Adult Asthma: A Prediction Model.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: November 02, 2025
Pharmacokinetics and Pharmacodynamics of Dapagliflozin in Obese and Nonobese Healthy Adults Following Multiple Administration.
Journal: Drug design, development and therapy
Published: October 13, 2025
Exploratory Evaluation of Solanidine as an Endogenous Marker for CYP2D6-Mediated Drug-Drug-Gene Interactions of Venlafaxine in Koreans.
Journal: Clinical and translational science
Published: October 09, 2025
Exploring LEPR-Linked Metabolic Diversity through Gut Microbiome-Metabolome Network Analysis in Non-Obese Adults.
Journal: Biomolecules & therapeutics
Published: August 22, 2025
Assessment of Pharmacokinetics and Food Effect of AD-109, a Novel Formulation of Rivaroxaban 18 mg.
Journal: Clinical and translational science
Published: August 05, 2025
High-resolution mass spectrometry imaging reveals metabolic signatures of Staphylococcus epidermidis in host defense against influenza A virus.
Journal: Analytica chimica acta
Published: July 14, 2025
Last Updated: 09/26/2026